Psychiatry

814 soru

Soru 81Soru →

A 38-year-old woman comes to the clinic seeking help to stop drinking alcohol. She reports consuming approximately half a bottle of wine every evening but expresses a strong desire to achieve total abstinence. She has been attending group counseling for the past month and feels motivated, but she requests medication to help manage her daily alcohol cravings. Her medical history is notable for opioid use disorder, which has been in sustained remission for the past 4 years on a stable dose of methadone. She has no other medical conditions. Vital signs are normal. Laboratory studies, including a comprehensive metabolic panel and complete blood count, are within normal limits. Which of the following is the most appropriate pharmacotherapy to promote alcohol abstinence in this patient?

Cevabı ve açıklamayı göster

Cevap: Acamprosate

Cevap

Acamprosate
The most appropriate pharmacotherapy for this patient is acamprosate. First-line pharmacological treatments for alcohol use disorder (AUD) include naltrexone and acamprosate. Naltrexone, a mu-opioid receptor antagonist, effectively reduces alcohol cravings and heavy drinking days. However, it is strictly contraindicated in patients who are currently taking opioid agonists (such as methadone or buprenorphine) or who have acute hepatitis or severe liver failure. Administering naltrexone to this patient, who is on methadone maintenance therapy, would immediately precipitate severe opioid withdrawal. Therefore, acamprosate is the correct choice. Acamprosate modulates glutamatergic transmission (acting as an NMDA receptor antagonist and GABA-A agonist) and is primarily cleared by the kidneys, making it safe for patients with liver disease or those on opioid therapy. It is highly effective for maintaining abstinence in motivated patients.

Adım Adım Çözüm

1
Identify the patient's primary clinical goal.
The patient is seeking pharmacotherapy to maintain abstinence from alcohol and reduce daily cravings.
Establishing the clinical goal (maintenance of abstinence versus acute withdrawal management) directs the choice of medication class.
2
Evaluate the patient's medical history for relevant contraindications.
The patient is actively taking methadone for opioid use disorder and has normal hepatic and renal function.
The first-line agents for alcohol use disorder include naltrexone and acamprosate, which have distinctly different contraindication profiles.
3
Select the appropriate first-line medication based on the patient's pharmacological profile.
Acamprosate is selected because naltrexone is strictly contraindicated in patients taking full opioid agonists.
Naltrexone is a mu-opioid antagonist and would precipitate severe acute opioid withdrawal if given to a patient on methadone. Acamprosate acts on glutamate and GABA systems and has no interaction with opioids.

Anahtar Kavram

Acamprosate is the preferred first-line pharmacotherapy for alcohol use disorder in patients who have contraindications to naltrexone, such as concurrent opioid agonist therapy or severe liver disease.
Soru 82Soru →

A 68-year-old retired mechanic is brought to the clinic by his wife due to excessive daytime sleepiness and frequent nighttime awakenings over the past two months. His wife reports that he sleeps restlessly and has episodes where he completely stops breathing for about 20 seconds at a time. The patient has a history of a myocardial infarction four years ago, type 2 diabetes mellitus, and hypertension. His current medications include metformin, low-dose aspirin, and amlodipine. Vital signs are temperature 37.0°C (98.6°F), blood pressure 118/76 mmHg, heart rate 92/min, and respiratory rate 18/min. BMI is 26 kg/m226 \text{ kg/m}^2. Physical examination reveals a laterally displaced point of maximal impulse, a faint third heart sound (S3), and trace bilateral lower extremity pitting edema. A polysomnography study demonstrates recurrent episodes of apnea without associated chest or abdominal wall movement, occurring between periods of a crescendo-decrescendo breathing pattern. Which of the following is the most appropriate initial step in the management of this patient's sleep disorder?

Cevabı ve açıklamayı göster

Cevap: Initiate furosemide and lisinopril therapy

Cevap

Initiate furosemide and lisinopril therapy
The correct answer identifies the need to treat the underlying cause of the patient's sleep disorder. The patient's polysomnography demonstrates central sleep apnea (apnea without respiratory effort) characterized by a crescendo-decrescendo tidal volume pattern. This is the hallmark of Cheyne-Stokes respiration, a condition driven by delayed circulation times and abnormal feedback loops in the respiratory control center, most commonly due to congestive heart failure. The physical exam confirms fluid overload and left ventricular dilation (displaced apical impulse, S3). For central sleep apnea caused by heart failure, the primary and initial intervention is to aggressively optimize the medical regimen for heart failure (e.g., initiating a loop diuretic like furosemide and an ACE inhibitor like lisinopril).

Adım Adım Çözüm

1
Interpret the polysomnography findings.
The study shows apneic episodes without chest or abdominal wall movement (lack of respiratory effort) interspersed with a crescendo-decrescendo breathing pattern.
This specific pattern defines Cheyne-Stokes respiration and central sleep apnea, differentiating it from obstructive sleep apnea where respiratory effort is maintained.
2
Correlate the sleep study pattern with the physical examination.
The patient has a laterally displaced point of maximal impulse, an S3 gallop, and peripheral edema.
These findings indicate decompensated congestive heart failure, which is the classic underlying cause of Cheyne-Stokes respiration.
3
Determine the most appropriate initial management.
The first-line intervention is to optimize the medical management of heart failure (e.g., using diuretics, ACE inhibitors, and beta-blockers).
Treating the underlying hemodynamic derangement in congestive heart failure often improves or resolves the associated central sleep apnea before specific airway interventions are required.

Anahtar Kavram

Central sleep apnea with Cheyne-Stokes respiration is heavily associated with advanced heart failure. The initial treatment is optimization of guideline-directed medical therapy for heart failure.
Soru 83Soru →

A 26-year-old woman is admitted to the medical ward for treatment of a localized methicillin-sensitive Staphylococcus aureus (MSSA) cutaneous abscess on her left forearm, which developed after a superficial self-inflicted laceration. She is currently receiving intravenous vancomycin. Her home medications include fluoxetine. Over the past 48 hours, she has been highly demanding, frequently yelling at nurses for 'ignoring' her, while praising the attending physician as her 'savior.' She has a long-standing history of intense, unstable relationships, chronic feelings of emptiness, and frequent, rapid mood shifts from extreme euphoria to deep dysphoria that last for a few hours, typically triggered by interpersonal conflicts. She reports that after a recent breakup, she heard voices telling her she was worthless for 2 days; this resolved without psychiatric intervention. Today, when told the attending physician is off duty, she becomes enraged, states she is being abandoned, and demands to be discharged immediately. She denies active suicidal ideation. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Switch vancomycin to intravenous cefazolin, establish strict behavioral limits with a unified medical team approach, and consult psychiatry for dialectical behavior therapy.

Cevap

The most appropriate management is to switch the antibiotic to intravenous cefazolin, establish strict behavioral limits with a unified medical team approach, and consult psychiatry for dialectical behavior therapy.
The correct answer accurately addresses both the infectious and psychiatric needs of the patient. From an infectious disease standpoint, the patient has a methicillin-sensitive Staphylococcus aureus (MSSA) infection, which should be treated with narrow-spectrum beta-lactams like cefazolin or nafcillin rather than broad-spectrum vancomycin to promote antibiotic stewardship. Psychiatrically, she exhibits classic features of Borderline Personality Disorder (BPD), including splitting (idealizing the attending, devaluing nurses), chronic emptiness, intense abandonment fears, self-harm, affective instability (mood shifts lasting hours), and transient stress-related micropsychotic episodes. The most appropriate immediate management on a medical ward is to prevent staff splitting through unified, consistent team communication and firm boundary setting. Long-term, dialectical behavior therapy (DBT) is the evidence-based treatment of choice.

Adım Adım Çözüm

1
Analyze the microbiological data and current pharmacological treatment.
The patient has an MSSA infection but is receiving broad-spectrum vancomycin.
To determine if the antibiotic regimen is appropriate; vancomycin should be switched to a targeted narrow-spectrum beta-lactam like cefazolin to promote antibiotic stewardship.
2
Evaluate the psychiatric symptom timeline and triggers.
The patient exhibits hour-to-hour mood shifts, chronic emptiness, splitting, and transient 2-day stress-related hallucinations.
To differentiate Borderline Personality Disorder (BPD) from Bipolar Disorder (requires days-to-weeks of mood shifts) and Schizophreniform Disorder (requires 1-6 months of psychosis).
3
Identify the safest pharmacological transition if psychiatric medications were to be changed.
The patient is on fluoxetine; switching to an MAOI requires a mandatory 5-week washout.
To rule out unsafe medication changes that could precipitate Serotonin Syndrome.
4
Determine the best immediate ward management for splitting behavior.
Establish strict behavioral limits with a unified medical team approach.
To prevent the patient from successfully turning staff members against each other, which severely disrupts medical care on the ward.

Anahtar Kavram

Management of Borderline Personality Disorder and MSSA infections on the medical ward
Tahmini Süre:3m 0s
Soru 84Soru →

A 32-year-old male is evaluated at the behavioral health center for profound distress. Five months prior, he witnessed a catastrophic scaffolding collapse at his construction site. Since the incident, he suffers from severe hyperarousal, nightly harrowing dreams about the collapse, and active avoidance of any construction zones. He feels emotionally estranged from his spouse. Over the previous six weeks, he has also manifested a severely depressed affect, extreme fatigue, and complete loss of interest in his usual recreational activities.

Review of his psychiatric history reveals an involuntary psychiatric admission at age 23. During that 18-day admission, he exhibited expansive mood, pressured speech, a perceived lack of need for sleep, and auditory hallucinations of a voice declaring him 'the chosen architect.' These hallucinations ceased entirely within days of mood stabilization.

Five days ago, the patient abruptly stopped taking phenelzine—prescribed by a different provider for his low mood—due to his inability to maintain the required dietary restrictions. He is currently taking no medications.

Which of the following represents the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Begin lithium and arrange for trauma-focused psychotherapy

Cevap

The most appropriate next step is to initiate a mood stabilizer that does not interact with MAOIs (like lithium) and refer the patient for trauma-focused psychotherapy.
The correct management strategy safely addresses this complex patient's multiple psychiatric conditions. He is suffering from Post-Traumatic Stress Disorder (PTSD) and a major depressive episode. However, his history of an 18-day hospitalization for expansive mood, decreased need for sleep, and psychotic features indicates an underlying diagnosis of Bipolar I Disorder. Furthermore, he discontinued phenelzine (an MAOI) only 5 days ago. Because MAOIs irreversibly inhibit monoamine oxidase, starting any serotonergic agent (like an SSRI) within 14 days risks life-threatening serotonin syndrome. Lithium is an effective mood stabilizer for bipolar depression that has no serotonergic interaction with MAOIs, making it safe to initiate immediately. Concurrently, trauma-focused psychotherapy is the first-line, evidence-based treatment for PTSD and carries no pharmacological risks.

Adım Adım Çözüm

1
Evaluate the current symptom profile against DSM-5 criteria.
The patient meets criteria for Post-Traumatic Stress Disorder (PTSD) and is currently experiencing a major depressive episode.
Establishing the current acute diagnoses identifies the primary targets for immediate treatment.
2
Analyze the past psychiatric history.
The prior 18-day hospitalization for expansive mood, decreased sleep, and hallucinations that resolved with mood stabilization confirms an underlying diagnosis of Bipolar I Disorder with psychotic features.
A history of mania fundamentally alters the pharmacological management of current depressive or anxiety symptoms.
3
Assess the pharmacological constraints imposed by recent medication use.
The patient discontinued phenelzine (an MAOI) 5 days ago. A strict 14-day washout period is required before starting any serotonergic medications.
MAOIs irreversibly inhibit monoamine oxidase; combining them (or starting serotonergic drugs before enzyme regeneration) causes life-threatening serotonin syndrome.
4
Select a safe and effective management plan that addresses all constraints.
Begin lithium and arrange for trauma-focused psychotherapy.
Lithium treats bipolar depression without serotonin syndrome risk, and trauma-focused psychotherapy is the first-line, non-pharmacological treatment for PTSD.

Anahtar Kavram

Complex management of PTSD and bipolar depression in the context of recent MAOI discontinuation.

Alternatif Yöntem

If lithium is contraindicated (e.g., due to severe renal impairment), valproate or an atypical antipsychotic approved for bipolar depression (such as quetiapine or lurasidone) could be initiated instead, as they also do not carry a risk of serotonin syndrome.
Tahmini Süre:2m 30s
Soru 85Soru →

You are evaluating five different patients who have recently initiated psychotropic medications. Each patient is now presenting with a specific adverse effect based on their history and examination findings. Which primary pharmacological mechanism best corresponds to the responsible medication for each patient's clinical presentation?

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with bulimia nervosa and normal vital signs presents with postictal confusion following a generalized tonic-clonic seizure shortly after starting a new antidepressant.
A 45-year-old man with depression and severe insomnia presents in acute distress with a painful, sustained penile erection lasting 6 hours after taking a newly prescribed sleep aid.
A 29-year-old woman with treatment-resistant depression presents with diaphoresis, severe anxiety on mental status exam, and a blood pressure of 220/115 mm Hg after attending a wine and aged cheese tasting.
A 55-year-old man with major depressive disorder and diabetic neuropathy presents with a euthymic mood but new-onset resting hypertension (155/95 mm Hg) following a dose increase of his medication.
A 24-year-old man treated for depression presents with significant recent weight gain (5 kg) and complains of profound daytime sedation and dizziness upon standing (orthostatic hypotension).

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Match each clinical presentation to the underlying mechanism of action of the responsible psychotropic medication: 1-Bupropion, 2-Trazodone, 3-MAOI, 4-SNRI, 5-Mirtazapine.
Bupropion causes seizures in patients with eating disorders due to NE/DA reuptake inhibition. Trazodone causes priapism via alpha-1 antagonism. MAOIs cause tyramine hypertensive crisis by inhibiting monoamine oxidase. SNRIs like venlafaxine cause dose-dependent hypertension via NE reuptake inhibition. Mirtazapine causes sedation, weight gain, and orthostasis via H1 and alpha-1/alpha-2 antagonism.

Adım Adım Çözüm

1
Analyze each clinical vignette to identify the specific psychotropic medication based on the unique adverse effect profile and the patient's history.
Identified medications: Bupropion (Left 1), Trazodone (Left 2), MAOI (Left 3), Venlafaxine/SNRI (Left 4), Mirtazapine (Left 5).
Recognizing the classic clinical presentation of drug-specific side effects is required before determining the mechanism of action.
2
Determine the pharmacological mechanism of action for each identified medication.
Bupropion inhibits NE/DA reuptake. Trazodone inhibits serotonin reuptake and blocks alpha-1 receptors. MAOIs irreversibly inhibit monoamine oxidase. Venlafaxine inhibits serotonin and dose-dependently inhibits NE reuptake. Mirtazapine blocks alpha-2 and H1 receptors.
Understanding the receptor-level activity explains why these specific adverse effects occur in these clinical scenarios.
3
Map the identified mechanism of action to the corresponding right item for each patient scenario.
All 5 pairs are successfully matched according to their pharmacological profiles.
This completes the matching process by synthesizing clinical diagnostics with neuropharmacology.

Anahtar Kavram

The mechanisms of action of psychotropic medications directly correlate with their unique and potentially dangerous adverse effect profiles.
Soru 86Soru →

A 25-year-old woman is brought to the outpatient psychiatric clinic by her sister due to a 4-week history of profound sadness, lack of motivation, and sleeping up to 14 hours daily. For the past week, the patient has been hearing an unfamiliar voice repeatedly telling her she is "hopeless and already dead." Her past psychiatric history is notable for a 3-week hospitalization two years ago when she exhibited extremely rapid speech, required only two hours of sleep per night, and harbored grandiose delusions about being a spiritual prophet. Following her discharge from that hospitalization, she returned to her baseline functioning and experienced no mood or psychotic symptoms until the current episode. The patient currently takes no medications. Vital signs are within normal limits. Laboratory evaluation reveals a thyroid-stimulating hormone (TSH) level of 1.4μU/mL1.4 \mu U/mL (normal: 0.5−5.0μU/mL0.5-5.0 \mu U/mL) and a free thyroxine (T4) level of 0.8ng/dL0.8 ng/dL (normal: 0.9−1.7ng/dL0.9-1.7 ng/dL). Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine

Cevap

Initiate quetiapine
The patient has a history of a distinct manic episode (decreased need for sleep, grandiose delusions, severe impairment requiring hospitalization), which establishes a diagnosis of Bipolar I Disorder. She is currently experiencing an acute major depressive episode with mood-congruent psychotic features. The most appropriate treatment for acute bipolar depression includes agents like quetiapine, lurasidone, or cariprazine. Quetiapine is particularly appropriate here as it is a second-generation antipsychotic that effectively treats bipolar depression while also addressing the patient's acute psychotic symptoms (auditory hallucinations).

Adım Adım Çözüm

1
Analyze the patient's psychiatric history.
The history of a manic episode with grandiose delusions two years ago establishes a diagnosis of Bipolar I Disorder.
A single manic episode is sufficient to diagnose Bipolar I Disorder, which dictates all future pharmacological management of mood episodes.
2
Evaluate the current clinical presentation.
The patient is experiencing a severe major depressive episode with mood-congruent psychotic features (hearing voices saying she is dead).
Identifying the current phase of the bipolar illness (acute depression with psychosis) is necessary to select an agent that targets both mood and psychosis.
3
Interpret the laboratory findings.
The normal TSH with a borderline low Free T4 rules out primary hypothyroidism as the cause of her severe depression.
Medical causes of depressive symptoms must be ruled out, but misinterpreting minor lab variations can lead to inappropriate treatment.
4
Select the most appropriate pharmacotherapy.
Quetiapine is selected as it is FDA-approved for bipolar depression and possesses antipsychotic properties.
Standard antidepressants (SSRIs) are contraindicated as monotherapy in Bipolar I due to the risk of manic switch, and the patient requires an agent that treats both depression and psychosis.

Anahtar Kavram

Management of acute bipolar depression with psychotic features involves avoiding antidepressant monotherapy and utilizing an atypical antipsychotic like quetiapine or lurasidone.
Soru 87Soru →

During morning rounds on a surgical ward, an internal medicine consultant is asked to evaluate a patient recovering from a right femoral neck fracture repair performed 48 hours ago. The nursing staff reports that the patient was awake, alert, and conversational yesterday, but overnight she became highly agitated, attempted to remove her urinary catheter, and claimed that insects were crawling on her bed sheets. The patient's daughter confirms her mother lived independently and had no history of memory issues or psychiatric illness prior to the fall. Physical examination reveals an inattentive patient who drifts off to sleep during questioning. Vital signs are stable, and a basic metabolic panel is unremarkable. Which of the following is the most likely diagnosis for this patient's acute presentation?

Cevabı ve açıklamayı göster

Cevap: Delirium

Cevap

Delirium
The correct answer is delirium. This patient presents with an acute change in mental status, marked inattention (drifting off during questioning), a fluctuating level of consciousness, and visual hallucinations (seeing insects) following a major surgery. These features, combined with a lack of prior cognitive impairment, are the classic clinical hallmarks of delirium. Delirium is a neurocognitive disorder that is typically secondary to an underlying medical condition, medication effect, infection, or the physiological stress of surgery.

Adım Adım Çözüm

1
Identify the timeline and onset of the patient's symptoms.
The patient developed acute behavioral changes and hallucinations over a matter of hours (overnight) on postoperative day 2.
Establishing the timeline helps distinguish acute conditions from chronic neurodegenerative diseases.
2
Analyze the specific clinical features present on examination.
The patient exhibits marked inattention, a fluctuating level of consciousness (drifting off to sleep), and visual hallucinations (seeing insects).
These specific signs are hallmark diagnostic features of a specific acute cognitive disorder.
3
Synthesize the findings to determine the most likely diagnosis.
An acute, fluctuating change in mental status with inattention in a hospitalized patient points directly to a secondary physiological effect rather than a primary psychiatric disorder.
Ruling out primary psychiatric illnesses and chronic cognitive decline confirms the diagnosis of delirium.

Anahtar Kavram

Clinical presentation and diagnostic criteria for delirium
Tahmini Süre:1m 0s
Soru 88Soru →

A 22-year-old college student presents to the university outpatient clinic reporting a 5-week history of feeling profoundly sad, crying frequently, and lacking the motivation to attend her classes. She reports sleeping up to 12 hours a day and eating significantly more than usual, resulting in a 4 kg (8.8 lb) weight gain. She has no significant past medical history, and her vital signs are within normal limits. Laboratory tests, including a complete blood count and thyroid-stimulating hormone (TSH) level, are normal. She currently takes no medications or illicit substances. The physician suspects a major depressive episode and plans to prescribe fluoxetine. Which of the following is the most appropriate next step in the clinical evaluation and management of this patient?

Cevabı ve açıklamayı göster

Cevap: Inquire about any past periods of persistently elevated mood, grandiosity, and decreased need for sleep

Cevap

Inquire about any past periods of persistently elevated mood, grandiosity, and decreased need for sleep
The correct next step is to screen for a history of manic or hypomanic episodes. This patient presents with a major depressive episode characterized by atypical features (hypersomnia, weight gain). Before initiating antidepressant monotherapy (e.g., fluoxetine), it is absolutely critical to rule out a history of bipolar disorder. Prescribing an antidepressant to a patient with unrecognized bipolar disorder can precipitate a manic or hypomanic episode (manic switch). Therefore, specifically asking about periods of persistently elevated mood, impulsivity, and decreased need for sleep is mandatory.

Adım Adım Çözüm

1
Identify the patient's primary syndrome
The patient meets criteria for a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis or weight gain).
Establishing the current episode is necessary before determining the treatment plan.
2
Evaluate the planned pharmacological intervention
The physician plans to prescribe an SSRI (fluoxetine).
Antidepressant monotherapy is the standard treatment for unipolar major depressive disorder.
3
Determine the critical prerequisite before initiating an antidepressant
A lifetime history of mania or hypomania must be ruled out.
If the patient has an undiagnosed history of mania or hypomania (Bipolar I or II disorder), SSRI monotherapy can precipitate a manic switch or rapid cycling. Therefore, screening for these symptoms is the most appropriate next step.

Anahtar Kavram

All patients presenting with a major depressive episode must be screened for a history of manic or hypomanic episodes before initiating antidepressant monotherapy to avoid precipitating a manic switch.
Soru 89Soru →

An unmarried 29-year-old accountant is referred for a psychiatric evaluation by his corporate human resources department due to ongoing interpersonal difficulties. For the past seven years, he has worked in an isolated cubicle and consistently refuses to attend team meetings or company events. During the clinical interview, the patient sits rigidly, avoids eye contact, and appears visibly apprehensive. He explains that he avoids his colleagues because he is convinced they are harboring malicious intentions and secretly sabotaging his energy fields. He notes that this intense anxiety persists even with colleagues he has known for years. He describes his mind as being 'tuned to a specialized frequency that intercepts cosmic warnings.' His speech is markedly abstract and circumstantial, yet it remains goal-directed without derailment or neologisms. He firmly denies ever experiencing auditory or visual hallucinations. A review of his medical history reveals that these eccentric behaviors and beliefs have been present continuously since his late teens, without distinct episodes of clinical deterioration or full recovery. He denies any periods of pervasive sadness or elevated mood. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizotypal personality disorder

Cevap

Schizotypal personality disorder
The correct diagnosis is Schizotypal personality disorder. This condition is a Cluster A personality disorder characterized by a pervasive pattern of social and interpersonal deficits, accompanied by cognitive or perceptual distortions and eccentricities of behavior. The patient's belief in 'cosmic warnings' (magical thinking), intense fear of colleagues' malicious intentions (paranoid social anxiety), odd and circumstantial speech, and lack of close relationships perfectly align with this diagnosis. Crucially, these traits have been present continuously since late adolescence without the emergence of frank delusions, true hallucinations, or gross disorganization, effectively ruling out primary psychotic disorders.

Adım Adım Çözüm

1
Analyze the patient's timeline and illness trajectory.
The patient has experienced stable, continuous symptoms since his late teens (over 7 years) without episodic deterioration or recovery.
Establishing chronicity helps rule out acute or episodic psychiatric conditions such as brief psychotic disorder and schizophreniform disorder.
2
Evaluate the specific psychiatric symptoms presented.
The patient exhibits magical thinking ('cosmic warnings'), paranoid social anxiety that does not diminish with familiarity, eccentric behavior, and circumstantial speech, but denies frank hallucinations and lacks disorganized thought.
Differentiating between eccentric personality traits (magical thinking, ideas of reference) and frank psychotic symptoms (fixed delusions, hallucinations) is necessary to rule out schizophrenia.
3
Synthesize the findings to determine the most accurate diagnosis.
The combination of lifelong social isolation, odd beliefs, perceptual distortions, and paranoid anxiety without true psychosis firmly establishes a Cluster A personality disorder diagnosis.
The diagnostic criteria for Schizotypal Personality Disorder perfectly encompass the patient's pervasive pattern of eccentricities and interpersonal deficits.

Anahtar Kavram

Schizotypal personality disorder is differentiated from schizophrenia spectrum disorders by its lifelong, pervasive pattern of eccentric behavior, magical thinking, and paranoid social anxiety, without the presence of frank delusions, hallucinations, or formal thought disorder.
Soru 90Soru →

A 35-year-old teacher visits her primary care physician due to chronic fatigue and neck pain. During the interview, she reveals that she feels constantly 'on edge' and struggles to control her worries. Over the last 7 months, she has experienced relentless anxiety concerning her family's health, financial stability, and school responsibilities, despite no recent changes in her life circumstances. She notes that these thoughts frequently prevent her from falling asleep. Physical examination is unremarkable, and recent laboratory studies, including thyroid-stimulating hormone levels, are within normal limits. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Generalized anxiety disorder

Cevap

Generalized anxiety disorder
The patient's presentation of excessive, uncontrollable worry about multiple issues (health, finances, work) lasting for at least 6 months, along with somatic symptoms (muscle tension, fatigue, sleep disturbance), perfectly aligns with the DSM-5 criteria for generalized anxiety disorder (GAD). The normal TSH levels appropriately rule out hyperthyroidism, a common medical mimic.

Adım Adım Çözüm

1
Analyze the primary symptoms and their duration.
The patient has excessive, uncontrollable worry about multiple everyday domains (family, finances, work) lasting for 7 months.
Duration is a critical diagnostic criterion for psychiatric disorders; greater than 6 months of excessive worry points toward generalized anxiety disorder.
2
Identify accompanying somatic symptoms.
The patient experiences chronic fatigue, neck pain (muscle tension), feeling 'on edge', and sleep disturbance.
Generalized anxiety disorder requires the presence of at least three associated somatic or cognitive symptoms, such as restlessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbance.
3
Rule out other potential causes.
Normal physical exam and TSH levels rule out hyperthyroidism. The absence of a specific stressor, panic attacks, or trauma rules out adjustment disorder, panic disorder, and acute stress disorder.
Psychiatric diagnoses are made after ensuring symptoms are not better explained by another medical condition, substance, or mental disorder.

Anahtar Kavram

Generalized anxiety disorder is characterized by excessive, difficult-to-control worry about multiple everyday issues lasting for at least 6 months, accompanied by somatic symptoms like muscle tension, fatigue, and sleep disturbance.
Soru 91Soru →

A 26-year-old woman is brought to the clinic by her sister due to a 5-week history of severe depression. The patient describes her mood as "bottomless" and complains that her arms and legs constantly feel "heavy as lead." She reports sleeping 14 to 16 hours daily and has gained 6 kg (13.2 lb) over the past month, which she attributes to intense carbohydrate cravings. Despite her profound sadness, the sister notes that the patient's mood brightened considerably yesterday when she was presented with a surprise gift, though she relapsed into despondency hours later. The patient has experienced two similar depressive episodes in the past. The sister confidentially shares that during the patient's sophomore year of college, there was a distinct 10-day period where she seemed "like a completely different person." During that time, she slept only 3 hours a night without feeling fatigued, rapidly repainted her entire apartment, and abruptly spent her tuition money on a business venture that never materialized. She has no significant past medical history. Physical examination is unremarkable. Which of the following is the most appropriate next step in pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine

Cevap

Initiate quetiapine
The correct answer is to initiate quetiapine. This patient is currently experiencing a major depressive episode characterized by atypical features, which include mood reactivity (brightening in response to positive events), hypersomnia, weight gain/hyperphagia, and leaden paralysis (heavy feeling in limbs). Crucially, her history reveals a distinct 10-day period of decreased need for sleep, increased goal-directed activity, and impulsivity. Because this elevated state lasted longer than 4 days and did not result in severe functional impairment or require hospitalization, it meets the criteria for a hypomanic episode. A history of at least one major depressive episode and at least one hypomanic episode establishes the diagnosis of Bipolar II disorder. For the acute treatment of bipolar depression, first-line pharmacotherapy includes specific atypical antipsychotics such as quetiapine, lurasidone, or cariprazine.

Adım Adım Çözüm

1
Identify the features of the current depressive episode.
The patient has leaden paralysis, hypersomnia, weight gain, and mood reactivity.
These specifically meet the DSM-5 criteria for a major depressive episode with atypical features.
2
Evaluate the patient's psychiatric history for periods of elevated mood.
The history reveals a 10-day period of decreased need for sleep, increased goal-directed activity, and impulsivity without severe impairment requiring hospitalization.
This establishes a history of a past hypomanic episode, which changes the primary diagnosis from Major Depressive Disorder to Bipolar II disorder.
3
Determine the appropriate pharmacotherapy for acute Bipolar II depression.
First-line agents include quetiapine, lurasidone, or cariprazine. Antidepressant monotherapy must be avoided.
Antidepressants can precipitate a manic or hypomanic switch in patients with bipolar disorder.

Anahtar Kavram

Bipolar II Disorder presenting as acute depression with atypical features
Soru 92Soru →

A 29-year-old woman presents to the clinic 4 weeks postpartum for a follow-up evaluation. She reports feeling profoundly sad, tearful, and unable to enjoy time with her newborn. She states, "I feel completely overwhelmed and guilty for being a terrible mother." She wakes up at 3:00 AM every day and is unable to fall back asleep, despite her husband handling the nighttime feedings. She has a poor appetite and has lost 4.5 kg (10 lb) since her delivery. She denies any thoughts of harming herself or her infant. She had an uncomplicated vaginal delivery but required a second-degree perineal laceration repair; she takes tramadol occasionally for residual pain. When reviewing her psychiatric history, she mentions that during her sophomore year of college, she experienced a distinct 5-day period where she felt "invincible," required only 2 hours of sleep per night, and started three different student organizations while speaking so rapidly her friends could hardly understand her. This college episode resolved spontaneously without hospitalization. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine

Cevap

Initiate quetiapine
This patient is experiencing a major depressive episode (depressed mood, anhedonia, sleep disturbance, weight loss, severe guilt) with peripartum onset. Crucially, her history of a 5-day period of elevated mood, decreased need for sleep, pressured speech, and increased goal-directed activity without hospitalization meets the criteria for a hypomanic episode. Therefore, her correct diagnosis is Bipolar II disorder. In patients with bipolar depression, monotherapy with standard antidepressants (such as SSRIs) is contraindicated because it can precipitate a hypomanic or manic switch. First-line evidence-based treatments for bipolar depression include certain atypical antipsychotics (e.g., quetiapine, lurasidone, cariprazine) or mood stabilizers. Quetiapine is an excellent choice for this patient, as it treats bipolar depression effectively and is frequently used during the postpartum period due to its well-established safety profile.

Adım Adım Çözüm

1
Evaluate the current mood episode based on the patient's presenting symptoms.
The patient presents with severe sadness, anhedonia, early morning awakening, weight loss, and guilt lasting 4 weeks postpartum, which meets the criteria for a major depressive episode with peripartum onset.
To establish the current clinical problem requiring intervention.
2
Analyze the patient's psychiatric history for prior mood episodes.
The patient describes a past 5-day episode of elevated mood, decreased need for sleep, increased goal-directed activity, and pressured speech that resolved without hospitalization, which meets the criteria for a hypomanic episode.
To differentiate between unipolar depression and bipolar depression, which fundamentally alters the treatment approach.
3
Synthesize the current and past history to determine the correct diagnosis.
A history of at least one hypomanic episode and at least one major depressive episode indicates a diagnosis of Bipolar II disorder.
To guide the selection of appropriate pharmacotherapy and avoid contraindicated agents.
4
Select the most appropriate pharmacotherapy for the patient's diagnosis.
First-line treatment for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, which treat depression without the risk of inducing a manic switch.
To provide safe and effective management while avoiding contraindicated medications like antidepressant monotherapy.

Anahtar Kavram

Patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania. If a history is present (indicating bipolar disorder), antidepressant monotherapy is contraindicated due to the risk of mood switch, and treatments like quetiapine or lurasidone are preferred.
Tahmini Süre:1m 30s
Soru 93Soru →

A 2626-year-old woman comes to the psychiatric clinic for a follow-up evaluation regarding persistent low mood, hypersomnia, and severe fatigue. She has an established diagnosis of bipolar II disorder. Six weeks ago, she began taking lamotrigine for a major depressive episode. Her dosage was gradually increased according to standard protocols to a maintenance dose of 200 mg200 \text{ mg} daily, which she has been taking consistently for the past 22 weeks. Despite medication adherence, the patient states she feels "just as depressed as before" and struggles to complete basic daily tasks. Her medical history is notable for polycystic ovary syndrome, which is well-controlled with a combined ethinyl estradiol and norgestimate oral contraceptive pill. Vital signs are within normal limits. Laboratory testing reveals a serum lamotrigine concentration of 1.2μg/mL1.2 \mu\text{g/mL} (therapeutic reference range: 3−15μg/mL3-15 \mu\text{g/mL}).

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Increase the dosage of lamotrigine

Cevap

Increase the dosage of lamotrigine
The correct intervention is to increase the dosage of lamotrigine. Lamotrigine is primarily metabolized in the liver via glucuronidation by the enzyme UDP-glucuronosyltransferase 1A4 (UGT1A4). Estrogen, a key component of combined oral contraceptive pills, is a potent inducer of UGT1A4. This enzymatic induction significantly accelerates the clearance of lamotrigine, often reducing serum concentrations by 50%50\% or more. Because this patient is symptomatic and has a confirmed subtherapeutic lamotrigine level resulting from this known pharmacokinetic interaction, the appropriate clinical step is to increase the lamotrigine dosage to achieve therapeutic efficacy. Often, female patients taking concurrent estrogen-containing contraceptives require up to double the standard maintenance dose of lamotrigine.

Adım Adım Çözüm

1
Identify the primary clinical problem.
The patient has bipolar II depression and is symptomatic despite taking a standard maintenance dose of lamotrigine, with objective laboratory evidence of a subtherapeutic drug concentration.
Establishing the baseline clinical status is necessary to determine if the current regimen is adequate.
2
Analyze the patient's medication list for potential pharmacokinetic interactions.
The patient is taking a combined oral contraceptive pill containing ethinyl estradiol.
Drug-drug interactions are a primary cause of subtherapeutic medication levels in psychiatry, particularly with mood stabilizers.
3
Determine the mechanism of the drug-drug interaction.
Estrogen is a potent inducer of UDP-glucuronosyltransferase 1A4 (UGT1A4), the primary hepatic enzyme responsible for the glucuronidation and clearance of lamotrigine.
Understanding this metabolic pathway explains why the lamotrigine level is significantly lower than expected for a compliant patient on a 200 mg200 \text{ mg} dose.
4
Select the safest and most effective clinical intervention.
The lamotrigine dosage must be increased to overcome the accelerated clearance and achieve a therapeutic serum level.
Adjusting the dose addresses the underlying pharmacokinetic issue without abandoning an effective first-line treatment or precipitating dangerous withdrawal toxicities.

Anahtar Kavram

Estrogen-containing oral contraceptives induce the glucuronidation (via UGT1A4) of lamotrigine, significantly decreasing its serum concentration and requiring a higher maintenance dose.
Tahmini Süre:1m 30s
Soru 94Soru →

A 22-year-old man is brought to the psychiatrist by his parents due to ongoing behavioral changes. Six weeks ago, the patient was hospitalized in the psychiatric unit for 4 days after presenting with severe agitation, auditory hallucinations, and paranoid delusions about being monitored by the government. At that time, his urine toxicology screen was markedly positive for amphetamines. He was discharged after brief treatment with haloperidol. His parents report that since discharge, he has lived at home and has been completely abstinent from all illicit drugs, a claim corroborated by weekly negative urine toxicology screens over the past 5 weeks. Despite his abstinence, the patient continues to experience daily auditory hallucinations of voices conversing about him and firmly believes his neighbors are tracking his movements. He has no prior psychiatric history, and there is no family history of psychiatric illness. His mood is described as 'fine,' and he exhibits no depressive or manic symptoms. Vital signs and physical examination are unremarkable. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizophreniform disorder

Cevap

Schizophreniform disorder
The correct diagnosis is schizophreniform disorder. While this patient's initial psychotic episode was undoubtedly triggered by amphetamine intoxication, his psychotic symptoms have persisted for 5 weeks despite documented, complete abstinence. According to DSM-5 criteria, if psychotic symptoms persist for more than 1 month after the cessation of acute substance intoxication or withdrawal, the condition must be reclassified as an independent, primary psychotic disorder rather than a substance-induced disorder. Because the patient's total duration of continuous illness is 6 weeks, the correct diagnosis is schizophreniform disorder. The timeline for schizophreniform disorder is defined as symptomatic manifestation lasting at least 1 month but less than 6 months.

Adım Adım Çözüm

1
Determine the temporal relationship between the patient's substance use and his psychotic symptoms.
The psychotic symptoms began in the context of acute amphetamine use but have persisted for 5 weeks despite verified abstinence.
According to DSM-5 criteria, a substance-induced psychotic disorder usually resolves within 1 month of substance cessation. Persistence beyond 1 month indicates an independent, primary psychotic disorder.
2
Calculate the total duration of the continuous psychotic episode.
The patient has experienced continuous psychotic symptoms (hallucinations and delusions) for a total of 6 weeks.
The total duration of symptoms is required to accurately differentiate among the primary psychotic disorders.
3
Classify the primary psychotic disorder based on the 6-week timeframe.
The 6-week duration falls in the 1-to-6 month window, making schizophreniform disorder the correct diagnosis.
Brief psychotic disorder is diagnosed for episodes lasting less than 1 month, whereas schizophrenia requires a duration of 6 months or longer.

Anahtar Kavram

Psychotic symptoms that persist for greater than 1 month after the cessation of substance use or withdrawal should be considered an independent primary psychotic disorder, requiring chronological classification (e.g., schizophreniform disorder for a 1-to-6 month duration).
Soru 95Soru →

A 28-year-old man is brought to the psychiatric clinic by his spouse. Over the past 3 weeks, the patient has slept only 2 hours per night, spoken at an unusually rapid pace, and claimed he is on the verge of single-handedly solving the global energy crisis. He also reports hearing the voices of angels who provide him with daily guidance. The spouse confirms this is his third episode of this nature in the past five years. Crucially, the spouse notes that even between these highly energetic episodes, during periods when the patient's mood is completely stable and normal for several months at a time, he continues to hear the angels' voices and firmly believes he possesses supernatural powers. A comprehensive medical and toxicological workup is negative. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Schizoaffective disorder

Cevap

Schizoaffective disorder
The most likely diagnosis is schizoaffective disorder. This condition is defined by an uninterrupted period of illness during which there is a major mood episode (manic or depressive) concurrent with active-phase symptoms of schizophrenia (such as delusions or hallucinations). The crucial defining feature that separates it from a primary mood disorder with psychotic features is the timeline criterion: the patient must experience delusions or hallucinations for 2 or more weeks in the strict absence of a major mood episode. Because this patient continues to experience auditory hallucinations and delusions for several months while his mood is completely stable, he strictly meets the criteria for schizoaffective disorder.

Adım Adım Çözüm

1
Identify the patient's clinical symptoms.
The patient exhibits signs of a manic episode (decreased need for sleep, rapid speech, grandiosity) as well as psychotic symptoms (auditory hallucinations, delusions).
Establishing the presence of both mood and psychotic domains is the first step in differentiating the diagnosis.
2
Determine the temporal relationship between the mood symptoms and the psychotic symptoms.
The psychotic symptoms persist for several months even when the patient's mood is completely stable (euthymic).
The timeline criterion (psychosis occurring in the absence of a mood episode for at least 2 weeks) is the definitive differentiator between a primary psychotic disorder and a mood disorder.
3
Select the diagnosis that perfectly matches this specific timeline pattern.
Schizoaffective disorder is the only condition characterized by prominent mood episodes accompanied by an underlying, independent psychotic illness.
Bipolar disorder with psychotic features would require the psychosis to resolve when the mania resolves.

Anahtar Kavram

Differentiating schizoaffective disorder from bipolar disorder with psychotic features based on the presence of psychotic symptoms during euthymic periods.
Soru 96Soru →

A 47-year-old male executive seeks psychiatric evaluation for profound sadness, early morning awakening, and severe anhedonia that have progressively worsened over the past four months. His past medical history is unremarkable, and he is currently taking no medications. Arrange the following therapeutic steps in the exact sequence recommended by standard clinical guidelines for the progressive pharmacological and procedural management of major depressive disorder. Assume that each step is implemented sequentially only after the preceding intervention has yielded an inadequate clinical response (either non-response or insufficient partial response) despite optimal dosing and duration.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: initiate an SSRI, switch to an SNRI upon non-response, augment with an atypical antipsychotic or lithium upon partial response, and finally utilize ECT for established treatment-resistant depression.
The established clinical algorithm for the progressive management of major depressive disorder prioritizes sequential, stepped interventions to balance efficacy and tolerability. The foundation of treatment begins with an initial monotherapy trial of a first-line agent, most commonly an SSRI. If the patient exhibits non-response after an adequate duration (typically 4-8 weeks at a therapeutic dose), the standard next step is to switch to a different monotherapy, often of another class such as an SNRI or an NDRI (like bupropion). Should this second trial yield only a partial response, the addition of an augmentation agent—such as a second-generation antipsychotic (e.g., aripiprazole, quetiapine), lithium, or triiodothyronine (T3)—is recommended to optimize the existing response. Finally, if the patient continues to experience severe, treatment-resistant depression after multiple failed trials of different pharmacologic classes and augmentation strategies, non-pharmacologic neuromodulation, specifically electroconvulsive therapy (ECT), is indicated as the definitive next step.

Adım Adım Çözüm

1
Determine the optimal initial treatment for the patient.
Select SSRI monotherapy.
The patient has a new, severe major depressive episode without prior treatment, making an SSRI the first-line standard of care.
2
Determine the next step following the failure of the initial monotherapy.
Switch to an alternative agent of a different class, such as an SNRI.
When a patient shows non-response to an adequate initial SSRI trial, clinical guidelines strongly recommend switching to another first-line agent, often from a different class.
3
Determine the management approach for an inadequate response to the second trial.
Augment the current therapy with an adjunctive agent like an atypical antipsychotic or lithium.
If the patient achieves only a partial response to the second antidepressant trial, augmentation is employed to boost efficacy rather than entirely abandoning the trial.
4
Identify the definitive approach for profound treatment resistance.
Refer for electroconvulsive therapy (ECT).
After the failure of multiple distinct medication trials involving different classes and augmentation, the patient meets criteria for treatment-resistant depression, making ECT highly appropriate and effective.

Anahtar Kavram

The stepped-care approach to treatment-resistant major depressive disorder requires a progressive escalation from SSRI monotherapy to switching medication classes, followed by augmentation strategies, and ultimately procedural interventions such as ECT.
Soru 97Soru →

A 73-year-old retired architect is evaluated in the hospital for severe agitation. He was admitted 24 hours ago for cellulitis of the right lower extremity, for which wound cultures grew methicillin-resistant *Staphylococcus aureus* (MRSA). His medical history is significant for bipolar I disorder (not currently taking mood stabilizers), severe osteoarthritis (managed with scheduled tramadol), and a 3-year history of progressive cognitive decline, prominent visual hallucinations of small animals, and a resting tremor. He has a documented diagnosis of major neurocognitive disorder with Lewy bodies.

Currently, he is severely agitated, attempting to pull out his intravenous line, and striking at the nursing staff. He is unable to cooperate with a medical examination or verbal de-escalation. His husband, who is his legally appointed healthcare proxy, requests that the medical team administer medication to calm him down. However, the patient's daughter, who just arrived, demands that no mind-altering medications be given and suggests using physical restraints instead.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administer low-dose quetiapine with the husband's consent

Cevap

The most appropriate next step is to administer low-dose quetiapine with the consent of the patient's husband.
The correct action is to administer low-dose quetiapine. This patient has major neurocognitive disorder with Lewy bodies (DLB) and is presenting with acute delirium secondary to an infection, resulting in dangerous agitation. In DLB, patients have a severe sensitivity to neuroleptics (antipsychotics with strong dopamine D2 receptor antagonism, such as haloperidol or risperidone), which can cause irreversible parkinsonism, impaired consciousness, and autonomic dysfunction. When non-pharmacological interventions fail and the patient poses an immediate danger to themselves or staff, the safest pharmacological options are low-dose quetiapine or clozapine, as they have the lowest D2 receptor affinity. Furthermore, the patient's husband is the legally appointed healthcare proxy; his consent for pharmacological treatment legally overrides the daughter's objections.

Adım Adım Çözüm

1
Identify the primary diagnosis and current acute complication.
The patient has Dementia with Lewy Bodies (DLB) and is experiencing acute hyperactive delirium secondary to an MRSA infection.
Understanding the underlying neurocognitive disorder is essential, as DLB dictates specific pharmacological contraindications.
2
Evaluate the ethical conflict regarding consent for treatment.
The husband's consent for pharmacological treatment is legally binding.
The husband is the legally appointed healthcare proxy, meaning his medical decisions override the conflicting requests of the daughter.
3
Select the most appropriate and safe intervention for severe agitation in DLB.
Low-dose quetiapine is the treatment of choice.
Patients with DLB have severe neuroleptic sensitivity. Typical antipsychotics and most atypicals (like risperidone) can cause life-threatening parkinsonism. Quetiapine has low D2 receptor affinity and is safer.
4
Rule out contraindicated medications based on the patient's history and current medication list.
Avoid linezolid (risk of serotonin syndrome with tramadol) and SSRI monotherapy (risk of manic switch in bipolar I).
Comprehensive management requires checking for dangerous drug-drug interactions and psychiatric contraindications.

Anahtar Kavram

Management of severe agitation in Dementia with Lewy Bodies (DLB)
Tahmini Süre:2m 0s
Soru 98Soru →

A 72-year-old woman is brought to the clinic by her son due to a 6-month history of progressive memory impairment, apathy, and severe psychomotor slowing. She frequently forgets conversations and has stopped participating in her usual social activities. She also reports worsening fatigue, constipation, and feeling cold constantly. Her medical history is significant for bipolar I disorder, which has been well-controlled on lithium monotherapy for 15 years, and hypertension. Current medications are lithium and lisinopril. Vital signs show a blood pressure of 130/80 mm Hg and a heart rate of 52/min. Physical examination reveals delayed relaxation of the deep tendon reflexes, dry skin, and a slightly puffy face. Cognitive assessment yields a Montreal Cognitive Assessment (MoCA) score of 19/30.

Laboratory results are as follows:

TestResultReference Range
Serum lithium0.8 mEq/L0.6-1.2 mEq/L
Thyroid-stimulating hormone (TSH)0.2 mIU/L0.4-4.0 mIU/L
Free thyroxine (T4)0.5 ng/dL0.9-1.7 ng/dL

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Magnetic resonance imaging of the brain

Cevap

Magnetic resonance imaging of the brain
This patient presents with a major neurocognitive decline accompanied by classical signs of hypothyroidism (bradycardia, delayed deep tendon reflexes, constipation, cold intolerance). In the workup of a neurocognitive disorder, evaluating for reversible causes is mandatory. Her laboratory findings reveal a low free T4 level, confirming hypothyroidism. However, her thyroid-stimulating hormone (TSH) level is inappropriately low. In primary hypothyroidism, the lack of negative feedback from T4 leads to a dramatically elevated TSH. A low or inappropriately normal TSH in the setting of low free T4 indicates secondary (central) hypothyroidism, pointing to a failure of the pituitary gland or hypothalamus. The most common causes of central hypothyroidism are structural lesions, such as a pituitary macroadenoma, craniopharyngioma, or other compressive intracranial masses. Therefore, the most appropriate next step in management is a magnetic resonance imaging (MRI) scan of the brain to visualize the hypothalamic-pituitary axis.

Adım Adım Çözüm

1
Identify the primary clinical syndrome.
The patient presents with reversible neurocognitive impairment (pseudodementia) accompanied by classic hypothyroid signs (bradycardia, delayed reflexes, cold intolerance, constipation).
Establishing the clinical phenotype is essential before interpreting laboratory values in the context of cognitive decline.
2
Interpret the thyroid function tests.
The free T4 is low (confirming hypothyroidism), but the TSH is inappropriately low (0.2 mIU/L), establishing a diagnosis of secondary (central) hypothyroidism.
Differentiating primary (high TSH) from secondary (low/normal TSH) hypothyroidism determines the anatomic location of the defect.
3
Differentiate the etiology from medication adverse effects.
Lithium induces primary hypothyroidism by inhibiting thyroid hormone release, which would elevate TSH. The patient's low TSH pattern rules out lithium-induced thyroid dysfunction.
Ruling out medication-induced effects prevents inappropriate cessation of a stable, long-term psychiatric regimen.
4
Determine the appropriate diagnostic intervention for central hypothyroidism.
Magnetic resonance imaging (MRI) of the brain is required.
Central hypothyroidism is most frequently caused by structural compressive lesions in the hypothalamic-pituitary axis (e.g., macroadenoma), which must be visualized radiographically.

Anahtar Kavram

Reversible neurocognitive impairment can be caused by central hypothyroidism (characterized by low free T4 and an inappropriately low TSH), which requires an MRI of the brain to evaluate for a pituitary or hypothalamic mass, independent of chronic lithium therapy which typically causes primary hypothyroidism (high TSH).
Soru 99Soru →

A 3131-year-old woman is evaluated in the emergency department for severe nausea, vomiting, diffuse muscle aches, and profound restlessness. She has a history of severe opioid use disorder. For the past three years, she has been maintained on a daily dose of 80 mg80\text{ mg} of methadone. Two days ago, her physician decided to transition her to sublingual buprenorphine-naloxone to provide more flexible outpatient management. She was instructed to wait until she felt withdrawal symptoms before taking her first dose. She took her last dose of methadone approximately 3636 hours ago. One hour ago, she took her first prescribed dose of sublingual buprenorphine-naloxone. Vital signs show a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 158/96 mm Hg158/96\text{ mm Hg}, pulse of 118/min118\text{/min}, and respirations of 18/min18\text{/min}. Physical examination reveals dilated pupils, excessive lacrimation, rhinorrhea, and piloerection. The patient's skin is clammy, and she is visibly shivering. She reports, "I thought this new medication was supposed to help, but I feel worse than I ever have." Which of the following is the most likely primary mechanism responsible for this patient's acute symptom presentation?

Cevabı ve açıklamayı göster

Cevap: Displacement of a full agonist by a partial agonist with higher receptor affinity

Cevap

The mechanism is the displacement of a full agonist (methadone) by a partial agonist (buprenorphine) that has a higher affinity for the mu-opioid receptor.
This patient is experiencing precipitated opioid withdrawal. Buprenorphine is a partial mu-opioid receptor agonist with very high receptor affinity—significantly higher than that of full agonists like methadone or heroin. When buprenorphine is administered to a patient who still has a full agonist occupying their receptors, the buprenorphine aggressively displaces the full agonist. Because buprenorphine has a lower intrinsic efficacy (as a partial agonist), the net opioid effect at the receptor abruptly drops. This sudden, steep decrease in opioid stimulation triggers severe withdrawal symptoms. Methadone has a prolonged half-life, meaning a significant amount remained in her system at 3636 hours. Transitioning from methadone to buprenorphine requires specialized protocols (such as cross-tapering or micro-dosing) to avoid this exact complication.

Adım Adım Çözüm

1
Identify the patient's clinical syndrome.
The patient is experiencing acute opioid withdrawal (mydriasis, piloerection, rhinorrhea, nausea, myalgias, tachycardia).
Vital signs and physical exam findings are classic for an adrenergic surge secondary to lack of opioid receptor stimulation.
2
Correlate the symptom onset with the timeline of medications.
The symptoms began explosively exactly one hour after the first dose of buprenorphine-naloxone, administered 36 hours after her last methadone dose.
Methadone has a very long half-life (2424-130130 hours). Significant levels of methadone were still occupying her mu-opioid receptors at 3636 hours.
3
Apply the pharmacodynamics of the administered medication.
Buprenorphine is a partial mu-opioid agonist with a very high binding affinity.
Because its affinity is higher than methadone's, it tightly binds to the receptors, rapidly displacing the remaining methadone.
4
Determine the net effect on the receptor.
The displacement of a full agonist (methadone) by a partial agonist (buprenorphine) causes a sudden, steep drop in overall mu-opioid receptor activation, precipitating severe withdrawal.
This is the classic presentation of precipitated withdrawal, which requires careful clinical management during transitions.

Anahtar Kavram

Buprenorphine is a partial mu-opioid receptor agonist with a higher binding affinity than most full agonists. Administering it to a patient with a full agonist still on their receptors will cause rapid displacement, leading to a net decrease in opioid effect and precipitated withdrawal.
Tahmini Süre:1m 30s
Soru 100Soru →

A 19-year-old female sophomore college student presents to the university health clinic seeking help for worsening sadness, low energy, and difficulty focusing on her coursework over the past four months. During the interview, she tearfully admits to intense dissatisfaction with her body weight. She describes periods where she consumes unusually large amounts of food in secret, immediately followed by the use of laxatives and self-induced vomiting. This cycle occurs almost daily. Her current body mass index is 22.1 kg/m2kg/m^2. Vital signs reveal a blood pressure of 105/65 mm Hg and a heart rate of 88/min. Physical examination notes bilateral parotid gland enlargement and abrasions on the dorsal aspect of her hands.

Basic metabolic panel results:
ParameterValueReference Range
Sodium139 mEq/L136-145 mEq/L
Potassium3.0 mEq/L3.5-5.0 mEq/L
Chloride90 mEq/L95-105 mEq/L
Bicarbonate33 mEq/L22-28 mEq/L
Arterial blood gas on room air:
ParameterValueReference Range
pH7.497.35-7.45
PaCO2PaCO_246 mm Hg35-45 mm Hg
PaO2PaO_292 mm Hg75-105 mm Hg

The patient asks about starting a medication to help with her mood and eating patterns. Which of the following is the most accurate statement regarding this patient's clinical picture and pharmacological management?

Cevabı ve açıklamayı göster

Cevap: Bupropion is absolutely contraindicated due to a significantly increased risk of precipitating generalized seizures.

Cevap

Bupropion is absolutely contraindicated due to a significantly increased risk of precipitating generalized seizures.
The correct answer identifies that bupropion is strictly contraindicated in patients with eating disorders. This patient's presentation of recurrent binge eating, compensatory purging, normal body mass index, parotid gland enlargement, and Russell sign (hand abrasions) is diagnostic for bulimia nervosa. Furthermore, her laboratory results reveal a hypokalemic, hypochloremic metabolic alkalosis—a hallmark of chronic vomiting. Bupropion is an atypical antidepressant that lowers the seizure threshold in a dose-dependent manner. In patients with bulimia nervosa or anorexia nervosa, underlying electrolyte abnormalities (such as hypokalemia and hyponatremia) already predispose them to a lowered seizure threshold. Consequently, administering bupropion in this population significantly increases the risk of generalized tonic-clonic seizures and represents an absolute contraindication.

Adım Adım Çözüm

1
Establish the primary psychiatric diagnosis based on the clinical history and physical examination.
The patient's recurrent binge eating followed by compensatory purging, normal BMI, parotid hypertrophy, and dorsal hand abrasions (Russell sign) confirm the diagnosis of bulimia nervosa.
Accurate diagnosis is required to select appropriate pharmacotherapy and anticipate specific medical complications.
2
Interpret the basic metabolic panel and arterial blood gas to determine the patient's physiological status.
The patient has a hypokalemic, hypochloremic metabolic alkalosis (HCO3−HCO_3^- 33 mEq/L, pH 7.49). Using the compensatory formula for metabolic alkalosis ("Expected"  PaCO2=40+0.7×ΔHCO3−"Expected"\; PaCO_2 = 40 + 0.7 \times \Delta HCO_3^-), the expected PaCO2PaCO_2 is roughly 46.3 mm Hg. Her PaCO2PaCO_2 of 46 mm Hg represents appropriate respiratory compensation.
Vomiting depletes fluid, H+H^+, Cl−Cl^-, and K+K^+, leading to characteristic acid-base derangements that can lower the seizure threshold and cause arrhythmias.
3
Identify pharmacological contraindications specific to the patient's diagnosis and metabolic state.
While fluoxetine is first-line for bulimia, bupropion is strictly contraindicated.
Bupropion lowers the seizure threshold in a dose-dependent manner. This risk is synergistically amplified by the electrolyte disturbances (like hypokalemia) seen in bulimia nervosa, making it highly epileptogenic in this population.

Anahtar Kavram

Pharmacological management and physiological complications of bulimia nervosa
Tahmini Süre:1m 30s
ÖncekiSayfa 5 / 41Sonraki
Psychiatry Alıştırma Soruları — USMLE Step 2 CK — Sayfa 5 | Examkin